33932867|t|Nicotinamide provides neuroprotection in glaucoma by protecting against mitochondrial and metabolic dysfunction.
33932867|a|Nicotinamide adenine dinucleotide (NAD) is a REDOX cofactor and metabolite essential for neuronal survival. Glaucoma is a common neurodegenerative disease in which neuronal levels of NAD decline. We assess the effects of nicotinamide (a precursor to NAD) on retinal ganglion cells (the affected neuron in glaucoma) in normal physiological conditions and across a range of glaucoma relevant insults including mitochondrial stress and axon degenerative insults. We demonstrate retinal ganglion cell somal, axonal, and dendritic neuroprotection by nicotinamide in rodent models which represent isolated ocular hypertensive, axon degenerative, and mitochondrial degenerative insults. We performed metabolomics enriched for small molecular weight metabolites for the retina, optic nerve, and superior colliculus which demonstrates that ocular hypertension induces widespread metabolic disruption, including consistent changes to alpha-ketoglutaric acid, creatine/creatinine, homocysteine, and glycerophosphocholine. This metabolic disruption is prevented by nicotinamide. Nicotinamide provides further neuroprotective effects by increasing oxidative phosphorylation, buffering and preventing metabolic stress, and increasing mitochondrial size and motility whilst simultaneously dampening action potential firing frequency. These data support continued determination of the utility of long-term nicotinamide treatment as a neuroprotective therapy for human glaucoma.
33932867	0	12	Nicotinamide	Chemical	MESH:D009536
33932867	41	49	glaucoma	Disease	MESH:D005901
33932867	72	111	mitochondrial and metabolic dysfunction	Disease	MESH:D028361
33932867	113	146	Nicotinamide adenine dinucleotide	Chemical	MESH:D009243
33932867	148	151	NAD	Chemical	MESH:D009243
33932867	221	229	Glaucoma	Disease	MESH:D005901
33932867	242	267	neurodegenerative disease	Disease	MESH:D019636
33932867	296	299	NAD	Chemical	MESH:D009243
33932867	334	346	nicotinamide	Chemical	MESH:D009536
33932867	363	366	NAD	Chemical	MESH:D009243
33932867	418	426	glaucoma	Disease	MESH:D005901
33932867	485	493	glaucoma	Disease	MESH:D005901
33932867	546	563	axon degenerative	Disease	MESH:D019636
33932867	658	670	nicotinamide	Chemical	MESH:D009536
33932867	713	732	ocular hypertensive	Disease	MESH:D009798
33932867	734	751	axon degenerative	Disease	MESH:D019636
33932867	757	791	mitochondrial degenerative insults	Disease	MESH:D019636
33932867	944	963	ocular hypertension	Disease	MESH:D009798
33932867	1037	1060	alpha-ketoglutaric acid	Chemical	MESH:D007656
33932867	1062	1070	creatine	Chemical	MESH:D003401
33932867	1071	1081	creatinine	Chemical	MESH:D003404
33932867	1083	1095	homocysteine	Chemical	MESH:D006710
33932867	1101	1122	glycerophosphocholine	Chemical	MESH:D005997
33932867	1166	1178	nicotinamide	Chemical	MESH:D009536
33932867	1180	1192	Nicotinamide	Chemical	MESH:D009536
33932867	1503	1515	nicotinamide	Chemical	MESH:D009536
33932867	1559	1564	human	Species	9606
33932867	1565	1573	glaucoma	Disease	MESH:D005901
33932867	Association	MESH:D003401	MESH:D009798
33932867	Negative_Correlation	MESH:D009536	MESH:D009798
33932867	Association	MESH:D007656	MESH:D009798
33932867	Negative_Correlation	MESH:D009243	MESH:D019636
33932867	Negative_Correlation	MESH:D009536	MESH:D019636
33932867	Negative_Correlation	MESH:D003404	MESH:D009536
33932867	Negative_Correlation	MESH:D007656	MESH:D009536
33932867	Negative_Correlation	MESH:D003401	MESH:D009536
33932867	Negative_Correlation	MESH:D009536	MESH:D028361
33932867	Association	MESH:D005997	MESH:D009798
33932867	Negative_Correlation	MESH:D006710	MESH:D009536
33932867	Negative_Correlation	MESH:D009243	MESH:D005901
33932867	Negative_Correlation	MESH:D009536	MESH:D005901
33932867	Negative_Correlation	MESH:D005997	MESH:D009536
33932867	Association	MESH:D003404	MESH:D009798
33932867	Association	MESH:D006710	MESH:D009798

